CU Programme of Idarucizumab for Japanese Patients (Q66398012)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CU Programme of Idarucizumab for Japanese Patients |
clinical trial |
Statements
A Compassionate Use Program of Idarucizumab for Reversal of the Anticoagulant Effects of Dabigatran in Japanese Patients Who Have Uncontrolled Bleeding or Require Emergency Surgery or Procedures (English)
0 references
22 July 2016
0 references
16 September 2016
0 references
1
0 references
20 year
0 references